{"organizations": [], "uuid": "5a2391faeec0f984edc63b1efccceb00caddbf6c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cas-group-announces-glass-lewis-re/brief-cas-group-announces-glass-lewis-recommendation-that-aviragen-stockholders-vote-against-merger-idUSFWN1PQ16E", "country": "US", "domain_rank": 408, "title": "BRIEF-CAS Group Announces Glass Lewis Recommendation That Aviragen Stockholders Vote Against Merger", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T16:16:00.000+02:00", "replies_count": 0, "uuid": "5a2391faeec0f984edc63b1efccceb00caddbf6c"}, "author": "", "url": "https://www.reuters.com/article/brief-cas-group-announces-glass-lewis-re/brief-cas-group-announces-glass-lewis-recommendation-that-aviragen-stockholders-vote-against-merger-idUSFWN1PQ16E", "ord_in_thread": 0, "title": "BRIEF-CAS Group Announces Glass Lewis Recommendation That Aviragen Stockholders Vote Against Merger", "locations": [], "entities": {"persons": [{"name": "lewis", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-cas group announces glass lewis recommendation that aviragen stockholders vote against merger", "sentiment": "negative"}, {"name": "brief-cas group announces glass lewis recommendation that aviragen st", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "vote against merger reuters staff", "sentiment": "none"}, {"name": "aviragen therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Aviragen Therapeutics Inc:\n* CAS GROUP ANNOUNCES GLASS LEWIS RECOMMENDATION THAT AVIRAGEN STOCKHOLDERS VOTE AGAINST MERGER AND EMPHASIZES VALUE OF TESLEXIVIR (BTA074) PROGRAM Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-31T16:16:00.000+02:00", "crawled": "2018-01-31T16:32:55.012+02:00", "highlightTitle": ""}